Sanara Financial Statements From 2010 to 2024

Stocks . USA . 
Stock . Sanara Medtech
SMTI Stock  USD 36.36  0.17  0.47%   
Sanara Medtech financial statements provide useful quarterly and yearly information to potential Sanara Medtech investors about the company's current and past financial position, as well as its overall management performance and changes in financial position over time. Historical trend examination of various income statement and balance sheet accounts found on Sanara Medtech financial statements helps investors assess Sanara Medtech's valuation, profitability, and current liquidity needs. Key fundamental drivers impacting Sanara Medtech's valuation are summarized below:
Gross Profit
39.5 M
Profit Margin
(0.11)
Market Capitalization
317.8 M
Enterprise Value Revenue
4.2722
Revenue
78.1 M
We have found one hundred twenty available fundamental trend indicators for Sanara Medtech, which can be analyzed and compared to other ratios and to its competition. Traders should compare all of Sanara Medtech current fundamentals against the fundamentals between 2010 and 2024 to make sure the company is sustainable this year. The current Market Cap is estimated to decrease to about 176.2 M. Enterprise Value is estimated to decrease to about 176.8 M

Sanara Medtech Total Revenue

68.24 Million

Check Sanara Medtech financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Sanara Medtech's main balance sheet or income statement drivers, such as Depreciation And Amortization of 3.9 M, Interest Expense of 499.6 K or Total Revenue of 68.2 M, as well as many indicators such as Price To Sales Ratio of 4.97, Dividend Yield of 0.0324 or PTB Ratio of 7.97. Sanara financial statements analysis is a perfect complement when working with Sanara Medtech Valuation or Volatility modules.
  
Check out the analysis of Sanara Medtech Correlation against competitors.
For more detail on how to invest in Sanara Stock please use our How to Invest in Sanara Medtech guide.

Sanara Medtech Balance Sheet

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Total Assets77.6 M73.9 M19.2 M
Slightly volatile
Short and Long Term Debt Total12.4 M11.8 M2.8 M
Slightly volatile
Other Current Liabilities11 M10.5 M3.4 M
Slightly volatile
Total Current Liabilities14.5 M13.8 M5.2 M
Slightly volatile
Property Plant And Equipment Net3.4 M3.3 M891.7 K
Slightly volatile
Accounts Payable2.1 M2 M580.8 K
Slightly volatile
Cash5.4 M5.1 M3.2 M
Slightly volatile
Non Current Assets Total57.6 M54.9 M11.9 M
Slightly volatile
Cash And Short Term Investments5.4 M5.1 M3.2 M
Slightly volatile
Net Receivables9 M8.5 M2.4 M
Slightly volatile
Common Stock Shares Outstanding8.7 M8.3 M3.4 M
Slightly volatile
Liabilities And Stockholders Equity77.6 M73.9 M19.2 M
Slightly volatile
Non Current Liabilities Total16.3 M15.5 M3.4 M
Slightly volatile
Other Current Assets638.8 K608.4 K293.4 K
Slightly volatile
Total Liabilities30.7 M29.3 M8.3 M
Slightly volatile
Total Current Assets20 M19 M7.3 M
Slightly volatile
Short Term Debt762.3 K1.3 M850.8 K
Slightly volatile
Common Stock8.1 K8.5 K65.7 K
Slightly volatile
Inventory5 M4.7 M1.4 M
Slightly volatile
Common Stock Total Equity9.1 K9.5 K62.2 K
Slightly volatile
Property Plant And Equipment Gross4.7 M4.4 M1.1 M
Slightly volatile
Current Deferred Revenue2 M1.9 M1 M
Slightly volatile
Intangible Assets47.2 M44.9 M9.3 M
Slightly volatile
Long Term Debt11 M10.5 M4.1 M
Slightly volatile
Short and Long Term Debt725.8 K667.4 K571.8 K
Slightly volatile
Property Plant Equipment1.7 M1.6 M606.8 K
Slightly volatile
Other Liabilities7.2 M6.9 M1.8 M
Slightly volatile
Long Term Investments3.1 M3.5 M2.3 M
Slightly volatile
Capital Stock8.1 K8.5 K902.7 K
Very volatile
Short Term Investments880 K990 K1.1 M
Slightly volatile
Capital Surpluse43.1 M75 M26.2 M
Slightly volatile

Sanara Medtech Income Statement

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Interest Expense499.6 K475.8 K346.4 K
Slightly volatile
Total Revenue68.2 M65 M17.4 M
Slightly volatile
Gross Profit60 M57.1 M15.1 M
Slightly volatile
Other Operating Expenses72.7 M69.2 M20.8 M
Slightly volatile
Cost Of Revenue8.2 M7.9 M2.4 M
Slightly volatile
Total Operating Expenses64.2 M61.1 M18.4 M
Slightly volatile
Selling General Administrative57.5 M54.8 M16.8 M
Slightly volatile
Reconciled Depreciation3.6 M3.4 M737.8 K
Slightly volatile
Research Development2.2 M4.1 M715.2 K
Slightly volatile
Non Recurring24 K27 K29.4 K
Slightly volatile

Sanara Medtech Cash Flow Statement

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Begin Period Cash Flow9.4 M9 M3.1 M
Slightly volatile
End Period Cash Flow5.4 M5.1 M3.2 M
Slightly volatile
Dividends Paid240.3 K253 K842.7 K
Pretty Stable

Financial Ratios

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Price To Sales Ratio4.975.23579.0927
Slightly volatile
Dividend Yield0.03240.03080.0206
Slightly volatile
Days Sales Outstanding79.2247.921966.602
Slightly volatile
Average Payables514.5 K490 K371.3 K
Slightly volatile
Stock Based Compensation To Revenue0.05030.0530.321
Slightly volatile
EV To Sales5.075.33799.3712
Slightly volatile
Inventory Turnover2.681.66461.7889
Very volatile
Days Of Inventory On Hand350219374
Slightly volatile
Payables Turnover3.733.922614.5902
Slightly volatile
Sales General And Administrative To Revenue1.751.151.4598
Slightly volatile
Average Inventory4.3 M4.1 M1.4 M
Slightly volatile
Research And Ddevelopement To Revenue0.03260.06360.0147
Slightly volatile
Capex To Revenue0.00390.00410.0261
Pretty Stable
Cash Per Share0.420.62170.683
Slightly volatile
Days Payables Outstanding88.493.049591.8636
Slightly volatile
Intangibles To Total Assets0.330.65690.2796
Very volatile
Current Ratio0.741.38051.3137
Slightly volatile
Receivables Turnover7.247.61666.6992
Slightly volatile
Graham Number7.567.958110.8142
Slightly volatile
Capex Per Share0.03040.0320.106
Pretty Stable
Average Receivables1.1 M1.1 M846.2 K
Slightly volatile
Revenue Per Share8.247.854.2152
Slightly volatile
Interest Debt Per Share1.211.2721.5277
Slightly volatile
Debt To Assets0.130.13610.6106
Slightly volatile
Operating Cycle398267278
Slightly volatile
Days Of Payables Outstanding88.493.049591.8636
Slightly volatile
Ebt Per Ebit1.031.05331.329
Pretty Stable
Quick Ratio0.561.03781.0364
Slightly volatile
Cash Ratio0.370.37390.6793
Slightly volatile
Cash Conversion Cycle183174177
Slightly volatile
Days Of Inventory Outstanding350219374
Slightly volatile
Days Of Sales Outstanding79.2247.921966.602
Slightly volatile
Free Cash Flow Operating Cash Flow Ratio0.911.08171.1439
Pretty Stable
Fixed Asset Turnover18.9819.977453.0733
Slightly volatile
Debt Ratio0.130.13610.6106
Slightly volatile
Price Sales Ratio4.975.23579.0927
Slightly volatile
Asset Turnover0.990.87981.4763
Pretty Stable
Gross Profit Margin0.920.87920.7513
Slightly volatile

Sanara Medtech Valuation Data

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Market Cap176.2 M306.2 M119.5 M
Slightly volatile
Enterprise Value176.8 M312.2 M117.8 M
Slightly volatile

Sanara Fundamental Market Drivers

Cash And Short Term Investments5.1 M

Sanara Upcoming Events

18th of March 2024
Upcoming Quarterly Report
View
20th of May 2024
Next Financial Report
View
31st of December 2023
Next Fiscal Quarter End
View
18th of March 2024
Next Fiscal Year End
View
30th of September 2023
Last Quarter Report
View
31st of December 2022
Last Financial Announcement
View

About Sanara Medtech Financial Statements

Investors use fundamental indicators, such as Sanara Medtech's revenue or net income, to determine how well the company is positioned to perform in the future. Although Sanara Medtech's investors may analyze each financial statement separately, they are all interrelated. Understanding these patterns can help investors make the right trading decisions.
Last ReportedProjected for Next Year
Current Deferred Revenue1.9 M2 M
Total Revenue65 M68.2 M
Cost Of Revenue7.9 M8.2 M
Stock Based Compensation To Revenue 0.05  0.05 
Sales General And Administrative To Revenue 1.15  1.75 
Research And Ddevelopement To Revenue 0.06  0.03 
Revenue Per Share 7.85  8.24 
Ebit Per Revenue(0.06)(0.07)

Currently Active Assets on Macroaxis

TITANTitan Company Limited
UUnity Software
PAYCPaycom Soft
HBIHanesbrands
STLDSteel Dynamics
When determining whether Sanara Medtech offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Sanara Medtech's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Sanara Medtech Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Sanara Medtech Stock:
How To Invest In Sanara
Details
Is Sanara Stock a good investment?
Details
What is Sanara Medtech's Net Worth?
Details
Largest Health Care Equipment & Supplies Companies
View
Largest Health Care Equipment & Services Companies
View
Check out the analysis of Sanara Medtech Correlation against competitors.
For more detail on how to invest in Sanara Stock please use our How to Invest in Sanara Medtech guide.
You can also try the Options Analysis module to analyze and evaluate options and option chains as a potential hedge for your portfolios.
Is Health Care Equipment & Supplies space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Sanara Medtech. If investors know Sanara will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Sanara Medtech listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
(0.99)
Revenue Per Share
9.241
Quarterly Revenue Growth
0.352
Return On Assets
(0.05)
Return On Equity
(0.20)
The market value of Sanara Medtech is measured differently than its book value, which is the value of Sanara that is recorded on the company's balance sheet. Investors also form their own opinion of Sanara Medtech's value that differs from its market value or its book value, called intrinsic value, which is Sanara Medtech's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Sanara Medtech's market value can be influenced by many factors that don't directly affect Sanara Medtech's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Altman
Z Score
Details
Piotroski
F Score
Details
Beneish
M Score
Details
Financial
Analysis
Details
Buy or Sell
Advice
Details
Earnings
Projections
Details
Please note, there is a significant difference between Sanara Medtech's value and its price as these two are different measures arrived at by different means. Investors typically determine if Sanara Medtech is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Sanara Medtech's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.
Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions
 
Feedback Blog
Made with optimal in San Francisco
2024 Macroaxis LLC
COMMON DESTINATIONS
MAIN CATEGORIES
COMPANY